Pediatric Radiology

, Volume 38, Issue 1, pp 30–39 | Cite as

Bilateral disease and new trends in Wilms tumour

  • Catherine M. OwensEmail author
  • Hervé J. Brisse
  • Øystein E. Olsen
  • Joanna Begent
  • Anne M. Smets


Wilms tumour is a great therapeutic success story within paediatric oncology; its prognosis is excellent. Although mainly sporadic, occurring in otherwise well children, it occurs in a small number of genetically predisposed children. Thus regular surveillance imaging is performed in predisposed children in parts of the USA and Europe. The risks and benefits of surveillance are unclear, as the existing ad-hoc surveillance protocols are lacking in consistency of practice and equity of provision. We present guidelines for Wilms tumour surveillance based on a review of current practice and available evidence, outlined by a multidisciplinary working group in the UK. Wilms tumours are bilateral in 4–13% of affected children. Bilateral synchronous nephroblastomas are observed in 5% of affected children and are usually associated with the presence of nephrogenic rests, congenital malformations and predisposing syndromes. The major challenge in bilateral disease is to achieve a cure and at the same time to preserve sufficient functional renal tissue for normal growth and development. The association among Wilms tumour, nephrogenic rests and nephroblastomatosis makes detection and characterization of renal lesions with imaging extremely important. We discuss the relative strengths and weaknesses of the different modalities used for diagnosis and follow-up in bilateral renal disease. We also discuss newly emerging diagnostic imaging tests such as 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). This technique, when fused with CT (PET-CT), allows accelerated metabolic activity to be accurately anatomically localised and so is potentially useful for staging, assessment of treatment response, and for surgical and radiotherapy planning. In addition, quantitative MRI techniques have been proved to be valuable in intracranial tumours, but no such role has been validated in abdominal disease. Diffusion-weighted imaging with calculation of ADC maps is feasible in abdominal tumours, and our own preliminary data suggest that tissue cellularity is an important determinant of ADC value, which might help in terms of early prediction of therapy response.


Bilateral Metachronous Synchronous Surveillance Nephroblastomatosis FDG-PET Quantitative MRI Children 


  1. 1.
    Scott RH, Walker L, Olsen OE et al (2006) Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child 91:995–999PubMedCrossRefGoogle Scholar
  2. 2.
    Pritchard-Jones K (2002) Controversies and advances in management of Wilms tumour. Arch Dis Child 87:241–244PubMedCrossRefGoogle Scholar
  3. 3.
    Pein F, Sakiroglu O, Dahan M et al (2004) Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour a the Institut Gustave Roussy. Br J Cancer 91:37–44PubMedCrossRefGoogle Scholar
  4. 4.
    Oeffinger KC, Hudson MM (2004) Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin 54:208–236PubMedCrossRefGoogle Scholar
  5. 5.
    Prorok PC (1992) Epidemiologic approach for cancer screening. Problems in design and analysis of trials. Am J Pediatr Hematol Oncol 14:117–128PubMedGoogle Scholar
  6. 6.
    Green DM, Breslow NE, Beckwith JB et al (1993) Screening of children with hemihypertrophy, aniridia and Beckwith-Wiedemann syndrome in patients with Wilms tumour: a report from the National Wilms Tumour Study. Med Pediatr Oncol 12:188–192CrossRefGoogle Scholar
  7. 7.
    Craft AW, Parker L, Stiller C et al (1995) Screening for Wilms tumour in patients with aniridia, Beckwith syndrome or hemihypertrophy. Med Pediatr Oncol 24:231–234PubMedCrossRefGoogle Scholar
  8. 8.
    Choyke PL, Siegel MJ, Craft A et al (1999) Screening for Wilms tumour in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 32:196–200PubMedCrossRefGoogle Scholar
  9. 9.
    DeBaun MR, Brown M, Kessler L (1996) Screening for Wilms tumour in children with high-risk congenital syndromes: considerations for an intervention trial. Med Pediatr Oncol 27:415–421PubMedCrossRefGoogle Scholar
  10. 10.
    Schmidt T, Hohl C, Haage P et al (2003) Diagnostic accuracy of phase-inversion tissue harmonic imaging versus fundamental B-mode sonography in the evaluation of focal lesions of the kidney. AJR 180:1639–1647PubMedGoogle Scholar
  11. 11.
    Petruzzi MJ, Green DM (1997) Wilms tumour. Pediatr Clin North Am 44:939–952PubMedCrossRefGoogle Scholar
  12. 12.
    Grundy PE, Green DM, Coppes MJ et al (2002) Renal tumours. In: Pizzo PA, Poplack DG (eds) Principles and practice of paediatric oncology. Lippincott Williams and Wilkins, Philadelphia, pp 865–893Google Scholar
  13. 13.
    Coppes MJ, Arnold M, Beckwith JB et al (1999) Factors affecting the risk of contralateral Wilms tumour development: a report from the National Wilms Tumour Study Group. Cancer 85:1616–1625PubMedCrossRefGoogle Scholar
  14. 14.
    Merchant SA, Badhe PB (1995) Nephroblastomatosis – pathologic and imaging characteristics. J Postgrad Med 41:72–80PubMedGoogle Scholar
  15. 15.
    Coppes MJ, de Kraker J, van Dijken PJ et al (1989) Bilateral Wilms tumour: long-term survival and some epidemiological features. J Clin Oncol 7:310–315PubMedGoogle Scholar
  16. 16.
    Horwitz JR, Ritchey ML, Moksness J et al (1996) Renal salvage procedures in patients with synchronous bilateral Wilms tumours: a report from the National Wilms Tumour Study Group. J Pediatr Surg 31:1020–1025PubMedCrossRefGoogle Scholar
  17. 17.
    Beckwith JB (1998) Nephrogenic rests and the pathogenesis of Wilms tumour: developmental and clinical considerations. Am J Med Genet 79:268–273PubMedCrossRefGoogle Scholar
  18. 18.
    Lonergan GJ, Martinez-Leon MI, Agrons GA et al (1998) Nephrogenic rests, nephroblastomatosis and associated lesions of the kidney. Radiographics 18:947–968PubMedGoogle Scholar
  19. 19.
    Perlman E, Dijoud F, Boccon-Gibod L (2004) Nephrogenic rests and nephroblastomatosis. Ann Pathol 24:510–515PubMedCrossRefGoogle Scholar
  20. 20.
    Rohrschneider WK, Weirich A, Rieden K et al (1998) US, CT and MR imaging characteristics of nephroblastomatosis. Pediatr Radiol 28:435–443PubMedCrossRefGoogle Scholar
  21. 21.
    Gylys-Morin V, Hoffer FA, Kozakewich H et al (1993) Wilms tumour and nephroblastomatosis: imaging characteristics at gadolinium-enhanced MR imaging. Radiology 188:517–521PubMedGoogle Scholar
  22. 22.
    Subhas N, Argani P, Gearhart JP et al (2004) Nephrogenic rests mimicking Wilms tumour on CT. Pediatr Radiol 34:152–155PubMedCrossRefGoogle Scholar
  23. 23.
    Choyke PL, Siegel MJ, Oz O et al (1998) Nonmalignant renal disease in paediatric patients with Beckwith-Wiedemann syndrome. AJR 171:733–737PubMedGoogle Scholar
  24. 24.
    Hoffer FA (2005) Magnetic resonance imaging of abdominal masses in the paediatric patient. Semin Ultrasound CT MR 26:212–223PubMedCrossRefGoogle Scholar
  25. 25.
    Berenyi P, Pinter J, Szokoly V (1990) Intraoperative sonography in organ preserving operations of kidney tumours. Z Urol Nephrol 83:419–424PubMedGoogle Scholar
  26. 26.
    Olsen OE, Sebire NJ (2006) Apparent diffusion coefficient maps of paediatric mass lesions with free-breathing diffusion-weighted magnetic resonance: feasibility study. Acta Radiol 47:198–204PubMedCrossRefGoogle Scholar
  27. 27.
    Daldrup-Link HE, Franzius C, Link TM et al (2001) Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR 177:229–236PubMedGoogle Scholar
  28. 28.
    Shulkin BL, Chang E, Strouse PJ et al (1997) PET FDG studies of Wilms tumours. J Pediatr Hematol Oncol 9:334–338CrossRefGoogle Scholar
  29. 29.
    Wegner EA, Barrington SF, Kingston JE et al (2005) The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging 32:23–30PubMedCrossRefGoogle Scholar
  30. 30.
    Humphries PD, Sebire NJ, Siegel MJ et al (2007) Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology DOI  2452061535
  31. 31.
    Tamai H, Takiguchi Y, Oka M et al (2005) Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med 24:1635–1640PubMedGoogle Scholar
  32. 32.
    Acenti G, Mazziotti S, Zimbaro G et al (2007) Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 243:158–165CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Catherine M. Owens
    • 1
    Email author
  • Hervé J. Brisse
    • 2
  • Øystein E. Olsen
    • 1
  • Joanna Begent
    • 4
  • Anne M. Smets
    • 3
  1. 1.Department of RadiologyGreat Ormond Street Hospital for Children NHS TrustLondonUK
  2. 2.Service de RadiodiagnosticInstitut CurieParisFrance
  3. 3.Department of RadiologyAcademic Medical Center AmsterdamAmsterdamThe Netherlands
  4. 4.Paediatric OncologyUniversity College HospitalLondonUK

Personalised recommendations